Steven Jacobs asserts to Will that if the ALZ-113 drug tested on chimpanzee boosts positive results for the chimp subject then it will have the same positive effect on humans. This is inaccurate; despite the fact that chimpanzees share 99.1% of their DNA with humans, their biology is still far too different to always guarantee the same results for humans. Jacobs' wild assumption also violates the FDA-required Phase III trials that new drugs be tested on groups of humans before final approval and distribution on the market. Reality Ensues as the ALZ-113 drug doesn't really do the same for humans as it did with chimps, bonobos, orangutans and gorillas.
Scritto da il 05/03/2025 alle ore 07:33

Consiglia

Voto

Nessun dato in archivio

Commenti

Nessun dato in archivio

Persone

Nessun dato in archivio

SerieTv

Nessun dato in archivio